Published in J Neurosci on December 15, 2010
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Alzheimer mechanisms and therapeutic strategies. Cell (2012) 5.24
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. J Neurosci (2013) 2.01
Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol (2012) 1.64
Lifespan brain activity, β-amyloid, and Alzheimer's disease. Trends Cogn Sci (2011) 1.63
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One (2011) 1.62
Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One (2011) 1.57
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation (2012) 1.57
Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Hum Brain Mapp (2011) 1.53
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun (2012) 1.48
Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing. PLoS One (2015) 1.47
Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Front Neurol (2011) 1.41
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation (2012) 1.36
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol (2014) 1.29
Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch Neurol (2012) 1.29
Alzheimer's disease: analyzing the missing heritability. PLoS One (2013) 1.28
CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease. PLoS One (2012) 1.21
c-Abl in neurodegenerative disease. J Mol Neurosci (2011) 1.15
Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement (2014) 1.15
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncol (2016) 1.13
Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J Clin Invest (2013) 1.12
Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nat Rev Neurol (2016) 1.10
The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin Cell Dev Biol (2013) 1.05
Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding. J Biol Chem (2012) 1.05
APOE genotype alters glial activation and loss of synaptic markers in mice. Glia (2012) 1.04
Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology (2011) 1.02
A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. PLoS One (2011) 0.98
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell (2013) 0.98
Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition. Front Aging Neurosci (2014) 0.96
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
Incorporation of cofilin into rods depends on disulfide intermolecular bonds: implications for actin regulation and neurodegenerative disease. J Neurosci (2012) 0.93
The DNA replication stress hypothesis of Alzheimer's disease. ScientificWorldJournal (2012) 0.93
Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci (2015) 0.92
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC Neurosci (2013) 0.92
Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H2O2-induced stress. PLoS One (2012) 0.92
Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory. Front Neurosci (2014) 0.92
Metallothionein and brain inflammation. J Biol Inorg Chem (2011) 0.90
The interesting interplay between interneurons and adult hippocampal neurogenesis. Mol Neurobiol (2011) 0.90
BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology. Neurotox Res (2011) 0.90
Genetics of Alzheimer's disease. Biomed Res Int (2013) 0.90
Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease. Alzheimers Dement (2013) 0.89
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci (2015) 0.89
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases. Mediators Inflamm (2015) 0.89
Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides. Proc Natl Acad Sci U S A (2012) 0.88
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease. Front Physiol (2013) 0.88
Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research. J Geriatr Psychiatry Neurol (2012) 0.88
Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus. Neurobiol Aging (2013) 0.88
Default mode network as a potential biomarker of chemotherapy-related brain injury. Neurobiol Aging (2014) 0.87
The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology. PLoS One (2013) 0.87
The "CPC clip motif": a conserved structural signature for heparin-binding proteins. PLoS One (2012) 0.86
Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress. Int J Mol Sci (2013) 0.86
Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease. Alzheimers Res Ther (2012) 0.85
The impact of the human genome project on complex disease. Genes (Basel) (2014) 0.85
A persistent stress response to impeded axonal transport leads to accumulation of amyloid-β in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer's disease. Neurodegener Dis (2011) 0.85
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease. BMC Neurol (2014) 0.84
Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci (2015) 0.84
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage. Front Aging Neurosci (2013) 0.84
Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem. Neurobiol Aging (2013) 0.83
Alzheimer's disease pathologic cascades: who comes first, what drives what. Neurotox Res (2011) 0.83
Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture. Alzheimers Dement (2011) 0.82
Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease. Front Aging Neurosci (2015) 0.82
Heat shock protein 70 in Alzheimer's disease. Biomed Res Int (2014) 0.82
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Neurosci Bull (2014) 0.81
Evidence of trem2 variant associated with triple risk of Alzheimer's disease. PLoS One (2014) 0.81
Rethinking on the concept of biomarkers in preclinical Alzheimer's disease. Neurol Sci (2016) 0.80
Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes. Mol Neurodegener (2015) 0.80
Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough. Imaging Med (2012) 0.79
In vitro aggregation assays using hyperphosphorylated tau protein. J Vis Exp (2015) 0.79
The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease. Acta Neuropathol Commun (2013) 0.79
Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci (2017) 0.79
Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance. Acta Pharmacol Sin (2016) 0.79
Early and sustained altered expression of aging-related genes in young 3xTg-AD mice. Cell Death Dis (2014) 0.78
Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol. Neurobiol Dis (2015) 0.78
Respiratory and sniffing behaviors throughout adulthood and aging in mice. Behav Brain Res (2011) 0.78
Mechanisms of neural and behavioral dysfunction in Alzheimer's disease. Mol Neurobiol (2011) 0.78
Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network Disruption. Front Neurosci (2016) 0.78
Interaction between amyloid-β pathology and cortical functional columnar organization. J Neurosci (2012) 0.78
Role of TGFβ signaling in the pathogenesis of Alzheimer's disease. Front Cell Neurosci (2015) 0.77
β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice. Neurobiol Aging (2013) 0.77
Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease. Front Aging Neurosci (2014) 0.77
Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants. Front Mol Neurosci (2012) 0.77
Heat shock proteins at the crossroads between cancer and Alzheimer's disease. Biomed Res Int (2014) 0.76
Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation. J Biol Chem (2014) 0.76
Insufficient resolution response in the hippocampus of a senescence-accelerated mouse model--SAMP8. J Mol Neurosci (2014) 0.76
Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort. Alzheimer Dis Assoc Disord (2016) 0.75
Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease. PLoS One (2013) 0.75
Intrinsic brain activity of cognitively normal older persons resembles more that of patients both with and at risk for Alzheimer's disease than that of healthy younger persons. Brain Connect (2014) 0.75
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease. Aging Dis (2015) 0.75
DNA damage in the oligodendrocyte lineage and its role in brain aging. Mech Ageing Dev (2016) 0.75
Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases. Hum Genet (2016) 0.75
Alterations of mitochondrial dynamics allow retrograde propagation of locally initiated axonal insults. Sci Rep (2016) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Alzheimer's disease is a synaptic failure. Science (2002) 13.82
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron (2007) 6.60
Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med (2006) 6.15
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol (1998) 5.42
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 5.29
Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet (2009) 5.15
Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell (2010) 5.09
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03
Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron (2009) 3.94
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest (2008) 3.36
Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol (2005) 3.34
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev (2008) 3.33
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci (2005) 3.20
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett (1987) 3.13
Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol (2009) 3.12
Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci (2007) 2.96
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci (2005) 2.94
Inflammatory processes in Alzheimer's disease. J Neuroimmunol (2007) 2.91
Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol (1998) 2.73
DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci (2001) 2.60
Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci (2010) 2.46
Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis (2009) 2.44
Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci (1998) 2.42
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23
Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol (2009) 2.22
Protective effects of NSAIDs on the development of Alzheimer disease. Neurology (2008) 2.21
The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol (2007) 2.19
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci (2003) 2.14
Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci (1996) 2.14
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Synaptic degeneration in Alzheimer's disease. Acta Neuropathol (2009) 1.93
Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des (2005) 1.87
Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci (2004) 1.86
Astroglia in dementia and Alzheimer's disease. Cell Death Differ (2008) 1.83
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol (2002) 1.82
Inflammation and neurodegenerative diseases. Am J Clin Nutr (2006) 1.76
Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol Sci (2008) 1.71
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol (2001) 1.66
Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci (2006) 1.60
Synaptic loss in Alzheimer's disease and other dementias. Neurology (1989) 1.57
Aneuploid neurons are functionally active and integrated into brain circuitry. Proc Natl Acad Sci U S A (2005) 1.53
Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci (2007) 1.52
The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease. Arch Neurol (2010) 1.46
Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport (1996) 1.42
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging (2001) 1.31
Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles? Mutat Res (2009) 1.28
Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J Neurosci (2008) 1.23
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest (2009) 1.23
Inflammation in Parkinson's disease. Adv Neurol (2001) 1.18
Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn (2002) 1.16
Selective cell death of hyperploid neurons in Alzheimer's disease. Am J Pathol (2010) 1.15
Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging (2001) 1.10
Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist (2002) 1.09
The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience (1998) 1.01
Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol (2000) 0.97
Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am J Physiol Cell Physiol (2002) 0.92
Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathol (2010) 0.91
Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines. Brain Res (1999) 0.91
Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging (1992) 0.89